NEW YORK (Reuters) - Austrian biotech company Intercell said it won't develop its Travelers' Diarrhea vaccine candidate and will post a much wider than expected 2010 loss, because the drug failed in clinical trials. (Source: Reuters: Health)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.
Read from Source
|
